FTY720 Attenuates 6-OHDA-Associated Dopaminergic Degeneration in Cellular and Mouse Parkinsonian Models
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FTY720 Attenuates 6-OHDA-Associated Dopaminergic Degeneration in Cellular and Mouse Parkinsonian Models
Authors
Keywords
FTY720, Parkinson’s disease, 6-OHDA, BDNF, Apoptosis
Journal
NEUROCHEMICAL RESEARCH
Volume 42, Issue 2, Pages 686-696
Publisher
Springer Nature
Online
2016-12-09
DOI
10.1007/s11064-016-2125-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FTY720/Fingolimod Reduces Synucleinopathy and Improves Gut Motility in A53T Mice
- (2016) Guadalupe Vidal-Martínez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Zonisamide reduces nigrostriatal dopaminergic neurodegeneration in a mouse genetic model of Parkinson's disease
- (2015) Hiromi Sano et al. JOURNAL OF NEUROCHEMISTRY
- FTY720 attenuates excitotoxicity and neuroinflammation
- (2015) Raffaela Cipriani et al. Journal of Neuroinflammation
- Sphingosine kinase 2 and sphingosine-1-phosphate promotes mitochondrial function in dopaminergic neurons of mouse model of Parkinson’s disease and in MPP+-treated MN9D cells in vitro
- (2015) M. Sivasubramanian et al. NEUROSCIENCE
- The Transfection of BDNF to Dopamine Neurons Potentiates the Effect of Dopamine D3 Receptor Agonist Recovering the Striatal Innervation, Dendritic Spines and Motor Behavior in an Aged Rat Model of Parkinson’s Disease
- (2015) Luis F. Razgado-Hernandez et al. PLoS One
- Fingolimod increases brain-derived neurotrophic factor levels and ameliorates amyloid β-induced memory impairment
- (2014) Kazuya Fukumoto et al. BEHAVIOURAL BRAIN RESEARCH
- Fingolimod for the treatment of neurological diseases—state of play and future perspectives
- (2014) Robert Brunkhorst et al. Frontiers in Cellular Neuroscience
- Novel FTY720-Based Compounds Stimulate Neurotrophin Expression and Phosphatase Activity in Dopaminergic Cells
- (2014) Javier Vargas-Medrano et al. ACS Medicinal Chemistry Letters
- Neurorestorative effect of FTY720 in a rat model of Alzheimer's disease: Comparison with Memantine
- (2013) Fatemeh Hemmati et al. BEHAVIOURAL BRAIN RESEARCH
- FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease
- (2013) Alba Di Pardo et al. HUMAN MOLECULAR GENETICS
- Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2/ARE signaling pathway
- (2013) Haiyan Lou et al. NEUROPHARMACOLOGY
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome
- (2012) R. Deogracias et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The establishment of a sensitive method in determining different neurotransmitters simultaneously in rat brains by using liquid chromatography–electrospray tandem mass spectrometry
- (2011) Kevin Y. Zhu et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Fingolimod (FTY720): A Recently Approved Multiple Sclerosis Drug Based on a Fungal Secondary Metabolite
- (2011) Cherilyn R. Strader et al. JOURNAL OF NATURAL PRODUCTS
- Fingolimod provides long-term protection in rodent models of cerebral ischemia
- (2010) Ying Wei et al. ANNALS OF NEUROLOGY
- FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system
- (2009) Volker Brinkmann BRITISH JOURNAL OF PHARMACOLOGY
- Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson’s disease
- (2009) Paula Scalzo et al. JOURNAL OF NEUROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search